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Functional Evolution and Structural Conservation
in Chimeric Cytochromes P450:
Calibrating a Structure-Guided Approach
P450s in the laboratory by recombination of homolo-
gous sequences. P450s typically exhibit low sequence
identity, and annealing-based DNA-shuffling techniques
[9–13] are not useful for creating highly diverse libraries
of P450 chimeras. While several methods for making
Christopher R. Otey,1 Jonathan J. Silberg,2
Christopher A. Voigt,4 Jeffrey B. Endelman,3
Geethani Bandara,2 and Frances H. Arnold1,2,3,*
1Biochemistry and Molecular Biophysics Option
2 Division of Chemistry and Chemical Engineering
3 Bioengineering Option such shuffled gene libraries independent of sequence
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Recently, we reported a computational algorithm,
SCHEMA, which can estimate the disruption caused bySummary
swapping different fragments among structurally similar
proteins and identify optimal crossover locations forRecombination generates chimeric proteins whose
making libraries by recombination [16, 17]. Using the 3Dability to fold depends on minimizing structural pertur-
structure of one of the parent proteins, the algorithmbations that result when portions of the sequence are
identifies pairs of amino acids that are interacting (e.g.,inherited from different parents. These chimeric se-
residues within a cutoff distance of 4.5 A˚) and deter-quences can display functional properties character-
mines the net number of interactions broken when aistic of the parents or acquire entirely new functions.
chimeric protein inherits portions of its sequence fromSeventeen chimeras were generated from two CYP102
different parents (E ). By comparing SCHEMA disruptionmembers of the functionally diverse cytochrome P450
predictions to functional -lactamases selected from afamily. Chimeras predicted to have limited structural
large library of chimeric sequences, we demonstrateddisruption, as defined by the SCHEMA algorithm, dis-
that sequences retaining the parental protein fold andplayed CO binding spectra characteristic of folded
function tend to have low E values [17]. This criterionP450s. Even this small population exhibited significant
can be used to select crossover positions for individualfunctional diversity: chimeras displayed altered sub-
chimeras or combinatorial libraries prepared by swap-strate specificities, a wide range in thermostabilities,
ping elements from related parent sequences.up to a 40-fold increase in peroxidase activity, and
Here we explore the effects of recombination in aability to hydroxylate a substrate toward which neither
larger and more complex enzyme, the cytochrome P450.parent heme domain shows detectable activity. These
Seventeen double-crossover chimeras were made byresults suggest that SCHEMA-guided recombination
swapping fragments between the heme domains of thecan be used to generate diverse P450s for exploring
soluble bacterial enzyme CYP102A1 (commonly referredfunction evolution within the P450 structural framework.
to as cytochrome P450 BM-3) and CYP102A2, which
are 460 amino acids in length and share 63% amino acid
Introduction identity. We have determined which sequences encode
properly folded heme domains and related those to the
The cytochrome P450 superfamily of enzymes exhibits disruption calculated by SCHEMA. To probe the functional
an impressive range of chemical activities and biological diversity of this small population, we have measured
roles. Nature has exploited these diverse enzymes for their stabilities and activities in different P450-catalyzed
everything from steroid biosynthesis to interspecies reactions. A subset of the heme domain chimeras has
chemical warfare, drug detoxification, and utilization of been reconstituted into holoenzymes by fusion with the
new food sources [1–5]. Individual members of the su- CYP102A1 reductase domain and characterized. These
perfamily, however, show a much narrower range of data will help to guide much larger efforts to explore
catalytic activities (usually catalyzing oxygen insertion the functional variation that is possible within the P450
into C-H bonds) and substrate specificities. The heme scaffold.
prosthetic group recruited by cytochrome P450 to effect
monooxygenation is also used by these and other pro-
teins for oxygen transport, electron transfer, reduction, Results
dealkylation, and dehalogenation [6, 7]. The highly ver-
satile cytochrome P450 family offers unique opportuni- Chimera Design
ties to investigate the evolution of function within a sin- For this work, we constructed chimeras of CYP102A1
gle structural framework [8]. [18] and CYP102A2, homologs from Bacillus megaterium
In this study, we begin to explore the generation of and Bacillus subtilis, respectively. Their 64% nucleotide
identity places them below the limits for effective recom-
bination using annealing-based (DNA-shuffling) meth-*Correspondence: frances@cheme.caltech.edu
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ods. (Our previous attempts to shuffle these genes
generated primarily the parental sequences, with few
chimeras.) These soluble fusion proteins, consisting of
a catalytic heme domain and an FAD- and FMN-con-
taining NADPH reductase [19], require dioxygen and a
cofactor (NADPH) for monooxygenase activity. How-
ever, the P450 heme domain can also utilize hydrogen
peroxide via the “peroxide shunt” pathway to catalyze
hydroxylation reactions. While this peroxygenase activ-
ity is low in CYP102A1, it is enhanced by the amino acid
substitution F87A [20, 21]; the equivalent F88A mutation
in CYP102A2 has a similar effect. The P450 chimeras
were constructed from the genes for the heme domains
of CYP102A1 with the F87A mutation and CYP102A2
with the F88A mutation (referred to herein as CYP102A1-h
and CYP102A2-h). With these mutations, we can use
the peroxygenase activity of the heme domain to explore
substrate specificities in the chimeras, without having
to supply cofactor or a reductase (which may or may
not interact properly with a chimeric heme domain). The
chimeric heme domains can also be fused to one of the
Figure 1. Effective Mutation and Disruption for Cytochrome P450
parental reductase domains to regenerate a chimeric Heme Domain Chimeras
holoenzyme (see below). Disruption values for all double-crossover chimeras with a minimum
The effective levels of mutation (amino acid Hamming insert size of 10 amino acids between CYP102A1-h and CYP102A2-h
distance from the closest parent) and SCHEMA disrup- were determined using the structure for the CYP102A1 heme do-
main. Disruption (E ) values from the substrate bound structure weretion (E ) were calculated for all possible double-cross-
used. For all double-crossover chimeras, the average E is 23.5 over chimeras of CYP102A1-h and CYP102A2-h with a
12.8, and average mutation m is 40.6  22.6. The 17 constructedminimum fragment size of ten amino acids. The distribu-
chimeras were assayed for the ability to fold and hydroxylate 12-
tion in the levels of disruption and effective mutation pNCA, 2-phenoxy-ethanol, and allyloxy-benzene: squares represent
(m ) for this population of chimeras can be seen in Figure chimeras that retain the ability to fold, and ’s indicate those that
1. Fourteen chimeras were individually designed and did not. Symbols denote chimeras that fold but have little or no
detectable peroxygenase activity (), chimeras with parent-like sub-constructed to encompass a broad range of E (2 to 42)
strate specificity profiles (), chimeras with altered profiles ( , ),and m (11 to 70) (Table 1). Crossovers were placed in
chimeras with altered profiles and (new) activity on allyloxy-ben-regions of low and high sequence identity. For three of
zene ( ).
the chimeras, we generated both “mirror” sequences,
i.e., chimeras that derive sequences from opposite par-
ents at every position. The other 11 sequences con-
in the chimeras: a reduced CO difference spectrum pro-
sisted of CYP102A1-h with an internal fragment derived
ducing a Soret band near 450 nm is indicative of heme
from CYP102A2-h.
incorporation and thus a correctly folded P450 heme
E values for the different chimeras were computed
domain [31]. A Soret band near 420 nm is indicative of
using the high-resolution structure for CYP102A1 with
a folded protein that binds heme but is catalytically
palmitoglycine bound in the active site [22]. Because
inactive due to a disrupted heme environment [32, 33].
previous studies have shown that substrate binding
Fourteen chimeras displayed detectable Soret bands:
causes a large conformational change in CYP102A1 [23–
thirteen appeared at 450 nm and one at 420 nm (Figure
25], we also calculated E using the substrate-free
2). Chimeras with low calculated disruption (E ) were
CYP102A1 structure [26]. As shown in Table 1, similar E
most likely to retain folded structures: all with E  30
values were obtained for the two calculations. Because
were folded, but less than half with E  30 yielded
both parents contain the same heme cofactor, contacts
detectable Soret bands (Table 1).
between the heme and the protein cannot be broken
upon recombination, at least in this simple model. It is
Peroxygenase Activities of Chimeric Heme Domainsassumed that chimeras retain parental heme contacts,
We assayed the chimeric P450 heme domains for hydrox-and heme is not included in the calculation of E.
ylation of p-nitrophenoxydodecanoic acid (12-pNCA), a
fatty acid analog that is hydroxylated by CYP102A1 and
CYP102A2 to yield p-nitrophenolate [34]. Initial ratesFolding of Chimeric Heme Domains
The chimeras were constructed using SOEing [27], were measured using a concentration of 12-pNCA (250
M) significantly higher than the KM of CYP102A1 for thiscloned into the IPTG-inducible pCWori vector [28], and
sequenced to confirm the absence of point mutations. substrate (KM  8.1 M [35]). Activities on 2-phenoxy-
ethanol and allyloxy-benzene were also determined, us-All proteins were overexpressed in a catalase-free strain
of E. coli [29], which allows the peroxygenase activity ing the 4-aminoantipyrine (4-AAP) assay, which is sensi-
tive to phenols and catechols [36]. This assay yields aof the heme domains to be monitored directly in cell
extracts [30]. We used carbon monoxide difference detectable product if hydroxylation occurs at the ortho
or meta positions of the aromatic ring or when hydroxyl-spectroscopy to assess the level of structural disruption
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Table 1. Properties of Designed CYP102A1-CYP102A2 Chimeric P450s
E (Substrate E (Substrate- Peroxidase
Proteina Bound)b Free)b mc Folded ( max)d Tm (	C) Activitye
CYP102A1-h – – – yes (448) 55 2.6  0.1
CYP102A2-h – – – yes (449) 44 0.4  0.1
364–403 2 2 13 yes (449) 51 1  0.2
165–256 7 7 36 yes (449) 48 16.1  1.4
165–256M [7] [7] 36 yes (448) 50 3.5  0.4
285–341 10 9 19 yes (448) 53 2.1  0.1
191–335 12 12 50 yes (449) 40 N.D.
169–197 12 10 11 yes (449) 52 100.3  3.1
169–197M [12] [10] 11 yes (449) 43 0.3  0.1
65–256 15 13 61 yes (447) 36 N.D.
118–194 20 19 20 yes (449) 47 34.3  1.2
70–299 21 19 70 yes (448) 42 0.8  0.3
46–73 27 30 16 yes (448) 55 6.8  0.5
277–365 27 28 33 yes (421) 39 N.D.
43–135 34 38 33 yes (448) 53 6.8  0.4
186–365 34 35 65 no – N.D.
186–365M [34] [35] 65 no – N.D.
50–140 38 39 32 yes (448) 52 10.4  0.6
345–448 42 43 34 no – N.D.
a CYP102A1-h and CYP102A2-h refer to the isolated heme domains of CYP102A1 (with the F87A substitution) and CYP102A2 (with the F88A
substitution). Chimera names correspond to the first and last residue of CYP102A2-h inserted into CYP102A1-h according to the numbering
of CYP102A1. “M” indicates mirror chimeras where CYP102A1-h is inserted into CYP102A2-h.
b SCHEMA-calculated disruption (see Experimental Procedures) based on substrate bound (1JPZ) and substrate-free structures (2HPD).
Brackets indicate assumed disruption for mirror chimeras (due to lack of crystal structure of CYP102A2).
c Effective level of mutation ( amino acid Hamming distance to closest parent).
d Folding as assayed by reduced CO difference spectroscopy. max for Soret band is reported.
e Values reported in nmol product/nmol P450/min. Activities  0.2 were not detectable (N.D.).
ation yields the hemiacetal, which decomposes to form only on 2-phenoxy-ethanol; neither showed measurable
peroxygenase activity toward allyloxy-benzene.phenol. At the maximum soluble concentrations of sub-
strate, the parent CYP102 heme domains were active Figure 3 compares the activities of the folded chimeric
heme domains to those of the parent enzymes. Unfolded
chimeras showed no activity toward any substrate, while
all but two of the folded ones retained peroxygenase
activity on at least one substrate. The P420 chimera
(277–365) was inactive toward all substrates tested. Sev-
eral chimeric heme domains were more active than the
best parent, CYP102A1-h, on one or more substrates.
Chimera 169–197 was the most active toward 12-pNCA,
46–73 had the highest activity on 2-phenoxy-ethanol,
and 43–135 and 165–256 were the most active on ally-
loxy-benzene. The chimeras also showed different
specificities, falling roughly into three groups: (1) chime-
ras with little or no detectable activity toward any sub-
strate; (2) parent-like chimeras, active on 12-pNCA and
2-phenoxy-ethanol; and (3) chimeras with altered sub-
strate specificities relative to the parents, due to loss
of activity toward 12-pNCA and/or acquisition of activity
on allyloxy-benzene. For the three chimeras with this
“novel” activity, one (165–256) had broadened specific-
ity and was active on all three substrates. The remaining
two (191–335 and 43–135) showed detectable activity
on 2-phenoxy-ethanol and allyloxy-benzene, but not 12-Figure 2. Reduced CO Difference Spectra for CYP102A1-h,
pNCA. The members of each pair of mirror chimeras hadCYP102A2-h, and Their Heme Domain Chimeras
equivalent folding properties but were not functionallySpectra were taken from 400 to 500 nm. The absorbance range for
equivalent.the first two rows is 
0.5 to 0.6, the third and fourth rows are
magnified 3 with a range of 
0.17 to 0.2, and the last row is
magnified 40 over the first row. Most chimeras exhibit a Soret Peroxidase Activities of Chimeric Heme Domains
band at 450  3 nm, characteristic of a folded P450 with correctly
P450s can reduce peroxide to water (and a proton) usingincorporated heme cofactor. Chimera 277–365 shows a Soret band
a mechanism similar to that of peroxidases [37], al-at 420 nm, and no Soret band could be detected for chimeras
186–365, 186–365M, and 345–448. though the intrinsic rate for P450s is orders of magnitude
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Figure 3. Substrate Activity Profiles of
CYP102A1-h, CYP102A2-h, and the Folded
Chimeric Heme Domains
Chimeras were assayed for peroxygenase
activity on 12-pNCA, 2-phenoxy-ethanol, and
allyloxy-benzene, and hierarchical clustering
analysis was used to group chimeras based
on their functional properties. Three major
categories are apparent: those with little or
no detectable peroxygenase activity, those
with parent-like profiles (activity on 12-pNCA
and 2-phenoxy-ethanol), and those with al-
tered profiles (below dashed line) relative to
the parents (resulting from loss of activity on
12-pNCA and/or gain of activity on allyloxy-
benzene). The average amino acid Hamming
distance (m) for the chimeras with parent-
like profiles is 22, whereas them of chime-
ras with altered profiles is 34. Initial rates are
reported in nmol product/nmol P450/min.
Chimeras with no detectable activity are
shown with values corresponding to the de-
tection limits, which were 0.1, 0.06, and 0.08
for 12-pNCA, 2-phenoxy-ethanol, and ally-
loxy-benzene, respectively. Chimeras lacking
detectable peaks in the CO difference spec-
tra showed no activity on the substrates as-
sayed.
slower. It has been proposed that the earliest P450 func- tention of catalytic activity: the two chimeras that lacked
peroxygenase activity were also the least thermostable.tion may have been as a peroxidase [2]. To investigate
how recombination affects P450 peroxidase activity, we
used the colorimetric substrate 2,2-azino-bis(3-ethyl- Folding and Monooxygenase Activities
benzothiazoline-6-sulfonate) (ABTS) to monitor this re- of Chimera-Reductase Fusion Proteins
action [38]. CYP102A1-h and CYP102A2-h both show We fused five of the functional chimeras (43–135, 46–73,
low, but detectable, peroxidase activity (Table 1). Chi- 118–194, 165–256, and 169–197) to the N terminus of
meras 50–140, 118–194, 165–256, and 169–197 have the CYP102A1 reductase domain in order to investigate
significantly higher peroxidase activities; 169–197 is ap- how the chimeric heme domains behave in the context
proximately 40-fold more active than the most active of a P450 holoenzyme. CO difference spectra of the
parent. Mirror chimeras 169–197M and 165–256M do not chimera-reductase fusion proteins (CRFPs) were used
show similarly enhanced levels of peroxidase activity. to monitor folding, and their activities on 12-pNCA,
Three folded chimeras, 191–335, 65–256, and 277–335, 2-phenoxy-ethanol, and allyloxy-benzene were measured
showed no detectable peroxidase activity. in the presence of dioxygen and NADPH. All five CRFPs
displayed a Soret band characteristic of a folded heme
domain, and four of the five exhibited detectable activityThermostabilities of Chimeric Heme Domains
Thermostability was assayed by monitoring the loss of on one or more substrates (Table 2). Monooxygenase
activities of the fusion proteins were comparable to thethe Soret band at increasing temperatures. Chimera
melting temperatures ranged from 36	C to 55	C (Table peroxygenase activities of the respective heme domains
for 12-pNCA and 2-phenoxy-ethanol. The fusion protein1), with none more stable than CYP102A1-h (Tm  55	C).
More than half of the folded chimeric heme domains monooxygenases were roughly an order of magnitude
more active toward allyloxy-benzene than were thewere more thermostable than CYP102A2-h (Tm  44	C);
the rest were less stable. We found that chimeras less heme domain peroxygenases.
Overall, recombination appears to affect the functionthermostable than the parents exhibited a wide range
of E values, 12 to 27, and that stability does not correlate of the heme domains and the reconstituted holoen-
zymes in similar ways. For example, the specificities ofwith calculated disruption, at least in this small popula-
tion. However, thermostability may be important for re- heme domain chimeras 118–194 and 169–197 are similar
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the parents (Figure 3). Recombination yielded enzymesTable 2. Monooxygenase Activities of Holoenzymes CYP102A1,
with detectable activity on only one or two of the sub-CYP102A2 and Chimera-Reductase Fusion Proteins, CRFPs,
strates analyzed as well as a broadly specific enzymeon Three Substrates
that hydroxylates all three. One specific heme domain2-Phenoxy- Allyloxy-
chimera (46–73) displayed 6-fold higher peroxygenaseProteina 12-pNCAb Ethanolc Benzenec
activity with 2-phenoxy-ethanol than the parent most
CYP102A1 90.9  10.2 1.8  .3 12.0  0.8 active on that substrate. Three chimeric heme domains
CYP102A2 4.7  0.7 N.D. N.D.
hydroxylated allyloxy-benzene, an activity not detect-43–135-CRFP N.D. 0.6  0.1 5.8  0.5
able in either of the parent heme domains.46–73-CRFP N.D. 3.9  0.1 54.2  3.7
118–194-CRFP 87.6  4.1 0.8  0.1 6.6  0.9 Using the heme domain’s peroxygenase activity to
165–256-CRFP N.D. N.D. N.D. monitor changes in substrate specificity allows us to
169–197-CRFP 67.9  6.1 1.2  0.1 10.3  1.4 explore the evolution of functional properties in this ver-
satile enzyme upon recombination. Because the three-a CYP102A1 has the F87A substitution, CYP102A2 has F88A. Chime-
ric heme domains were fused to the N terminus of the CYP102A1 dimensional structure of the holoenzyme is not avail-
reductase domain. able, the SCHEMA algorithm can only be applied to
b Reported in nmol product/nmol P450/min. Activity less than 0.1 the heme domain. The peroxygenase activity therefore
was not detectable (N.D.).
provides a convenient way to screen chimeric enzymec Reported in nmol product/nmol P450/min. Activity less than 0.2
libraries; it is also interesting in its own right for potentialwas not detectable (N.D.).
applications of this enzyme in chemical synthesis [30].
A chimeric heme domain can also be reconstituted into a
holoenzyme by addition of a CYP102 reductase domain.
to CYP102A1-h and CYP102A2-h (see Figure 3); their Four of the five such CRFPs that were constructed in fact
holoenzyme counterparts (118–194-CRFP and 169–197- functioned as monooxygenases (Table 2). Furthermore,
CRFP) are also similar to the full-length parent with the two active CRFPs whose heme domains showed
which they retain the most sequence similarity, altered substrate specificity relative to the parent heme
CYP102A1 (Table 2). Furthermore, the chimeric heme domains were also different from the parent holoen-
domains 46–73 and 43–135, which showed altered per- zymes. The activity and specificity of a chimeric heme
oxygenase activity profiles relative to the parents, also domain can be expected to change, however, when it
exhibited different oxygenase specificity (no activity to- is used in a CRFP as a monooxygenase, just as the
ward 12-pNCA) when assembled as the holoenzyme. parent enzymes differ in their peroxygenase and mono-
165–256-CRFP, on the other hand, exhibited no detect- oxygenase activities. Such differences were also re-
able oxygenase activity on any of the test substrates, ported in our previous study of CYP102A1 peroxy-
unlike 165–256, which as a peroxygenase hydroxylated genase regioselectivity [21].
all three. One of the functional heme domain chimeras (165–
The lower activity of CYP102A2 (having the F88A sub- 256) generated an inactive CRFP. Upon recombination,
stitution) relative to CYP102A1 (with F87A) is more ap- the region of sequence that is derived from parent
parent as a monooxygenase than as a heme domain CYP102A2 introduces a glutamic acid residue in place
peroxygenase. CYP102A1 was active on all three sub- of a lysine at position 241, located at the interface be-
strates tested, whereas the activity of CYP102A2 was tween the heme and reductase domains. We believe this
measurable only on 12-pNCA, where it was 50 times impairs electron transfer by disrupting an electrostatic
less active than CYP102A1. If CYP102A2 has a substrate interaction between the reductase and heme domains
specificity similar to its A1 homolog, then the activities of CYP102A1 [47]. None of the other CRFPs had this
on allyloxy-benzene and 2-phenoxyethanol would be mutation. Because a chimeric heme domain may not in
below the detection limit of the assay. Although general fact be compatible with a specific parental reductase,
features were similar, the CRFPs differed from their re- it is preferable to assay for the presence of function
spective heme domain chimeras in the details of the directly in the heme domain chimeras in order to assess
activities and specificities. the effects of recombination.
Our finding that recombination is effective in creating
Discussion P450 chimeras with altered substrate specificities and
novel activities is consistent with those reported for re-
Activities and Specificities of Recombined P450s combination of homologs in other enzyme families [41–
While a chimeric protein often equals the sum of its 45] and with mammalian P450s [46, 48]. In most of these
parts [39], it is also possible for a chimera to exceed its studies, closely related proteins exhibiting distinct sub-
parents and find amino acid combinations that allow strate specificities or activities were recombined. For
new properties to emerge [40–46]. Creating these bene- example, Raillard and coworkers shuffled two triazine
ficial amino acid combinations from different parental hydrolases, AtzA and TriA, which catalyze dechlorina-
sequences that are “prescreened” by nature is one goal tion and deamination reactions, respectively, to obtain
of protein engineering by recombination [41]. We find chimeras with enhanced activities and novel substrate
that recombination is an effective way to alter the func- specificities [43]. Our results demonstrate that recombi-
tion of bacterial cytochrome P450s—more than half the nation of functionally similar enzymes can also yield
folded P450 chimeric heme domains surpassed the par- functionally diverse chimeras. In a previous study in
ents in peroxidase or peroxygenase activity. In addition, which functionally similar cephalosporinases were shuf-
fled [41], the high levels of point mutation made it impos-nearly half had altered substrate specificities relative to
Chemistry & Biology
314
Figure 4. Structural Models of Chimeric Cytochrome P450 Heme Domains
The numbers shown for each chimera represent the residues from CYP102A1 that have been swapped for those from CYP102A2.
(A) Residues from CYP102A1 (dark gray) and CYP102A2 (light gray) are mapped onto the structure of the CYP102A1 heme domain [22]. Arrows
indicate the F and G helices.
(B) Most of the effective mutations in the chimeras (shown in yellow) are located on the surface of the protein.
sible to deconvolute the effects of recombination and ever, it is unclear to what extent, if at all, sequence
point mutation. Here we show that residues that appear changes at these sites contribute to altered functional
to be functionally neutral in the parent proteins are able properties, since no single change or combination of
to confer altered properties when recombined, provided them is responsible for a particular activity. This sug-
the novel sequence folds properly. Although they may gests that mutations outside the active site effectively
well be useful, additional point mutations were not re- modulate substrate specificities and activities, as has
quired to achieve functional diversity. been observed in previous random mutagenesis studies
[52–54]. The “novel” activity on allyloxy-benzene and
altered substrate specificity profiles cannot be attrib-Structural Features of Chimeric Heme Domains
uted to any specific residue alterations, since chimerasThe chimeric heme domains that retain the ability to fold
exhibiting similar changes in activity arose by swappingand/or function did not result from swapping recogniz-
distinct polypeptides in different places in the enzymeable structural domains or distinct secondary structural
(Figure 3). Clearly, there are multiple ways to evolveelements. Instead, as illustrated in Figure 4A, the
functionally similar enzymes through recombination ofswapped fragments encompass nontrivial structural el-
homologous proteins at structurally related residues.ements that would be difficult to identify without using
We nonetheless point out one structural anecdote.an algorithm like SCHEMA, which takes into account
The P450 heme domain chimeras with the highest perox-sequence identity when calculating disruption. Using
idase and peroxygenase rates (169–197) and broadeststructural compactness alone to identify modules (for
substrate specificity (165–256) have both swapped aexample, using the centripetal definition of Go [49, 50]),
region of amino acids comprising the F helix. It hasdoes not identify most of our swapped elements as
been shown that the F and G helices (Figure 4A) moveexchangeable. A great majority of the crossovers in the
approximately 6 A˚ upon substrate binding [23–25], andfolded chimeras occur within these compact elements,
mutations affecting catalytic activity have been ob-rather than at their boundaries (data not shown).
served there in other protein engineering studies [54].For proteins that share 63% amino acid sequence
The new, favorable combination of the F helix fromidentity, most nonshared amino acids are on the protein
CYP102A2 and the G helix from CYP102A1 in the hemesurface. Not surprisingly, therefore, most of the se-
domain chimera 169–197 and the complete substitutionquence changes in the chimeras are found on the exte-
of the F and G helices in CYP102A1 with that fromrior of the protein (Figure 4B). Such mutations are less
CYP102A2 in the heme domain chimera 165–256 indi-disruptive, on average, than changes in the core.
cate a key role of this region in determining P450 cata-CYP102A1 and CYP102A2 differ at six of the 21 residues
postulated to contact a fatty-acid substrate [51]. How- lytic properties.
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Structure-Guided Design of Chimeric
Enzyme Libraries
Libraries generated by recombination of homologous
proteins are rich in folded proteins if the parent proteins
are highly similar [44, 55] or if appropriate structural
information is incorporated in the library design [16, 17].
It is not known, however, how functional diversity de-
pends on the level of sequence diversity in such libraries,
and whether recombination of less similar sequences
provides any advantage in the search for improved or
novel functions. We hope that our studies will begin
to address this question. Figure 1 shows how chimera
function is related to calculated disruption and effective
mutations. Among the folded chimeras, those with sub-
strate activity profiles similar to the parents typically
cluster together with lower average mutation (m 
22) than those with altered profiles (m  34). Thus,
chimeras with higher levels of mutation, provided they
fold, may be more likely to have altered properties, while
those with lower levels of mutation tend to be more
similar to the parents. Theoretical models predict that
recombination facilitates fitness changes [56, 57], but Figure 5. Theoretical Library Analysis
we still have little information on how recombination 5000 libraries were generated in silico, in which 10 randomly se-
mutation level relates to functional evolution. lected crossovers were allowed between CYP102A1-h and
CYP102A2-h. The fraction of each library that is predicted to beThe probability of retaining function in the P450 chi-
folded (F30, those with E  30) is plotted against the average levelmeras decreases as calculated disruption (E  total
of effective mutation for the fraction that should fold (m30). Thenumber of residue-residue contacts broken upon re-
average m30 and F30 for the population is shown as a square withcombination) increases. P450 chimeras with as many one standard deviation. The arrow points to a library with a F30 of
as 50, 61, and 70 effective mutations were still able to 75% with m30 greater than 50.
properly incorporate a heme cofactor, particularly with
chimeric sequences characterized by low calculated
disruption (typically E  30) (Table 1). We found very
using SCHEMA to guide the choice of crossover points,
similar results in a recent study of more than 16,000
the percentage folded can in principle be as high as
chimeric lactamases [17]. Thus, we believe that E is a
75%, and a very high effective level of mutation can
useful measure of the likelihood a chimeric protein will
be retained (with 50 mutations on average per folded
retain its structure.
sequence). We propose that this latter library will contain
Taking together the experimental results and disrup-
more folded chimeras and be richer in novel functionaltion calculations, we have in effect “calibrated” this cyto-
proteins than libraries made at random. We expect evenchrome P450 pair with respect to recombination. For
greater benefits of using SCHEMA when recombiningexample, we can now predict that a large fraction of all
more parents or parental sequences with less sequencepossible double-crossover chimeras of CYP102A1-h and
identity, provided their structures are highly similarCYP102A2-h will fold properly, because most are char-
overall.acterized by values of E  30–35 (Figure 1). Once a
particular set of crossover positions has been selected,
however, only a limited number of chimeric sequences
Significancecan be made (for two parents, this is 23  8 sequences,
including the parental ones). In generating large libraries
In nature, cytochromes P450 often protect organismsthat incorporate multiple crossovers, reducing disrup-
from toxic compounds [3, 5] or help them adapt totion becomes an important design criterion. Figure 5
new food sources [4, 5]. Thus, a scaffold that allowsshows an in silico analysis of 5000 different libraries in
for rapid functional evolution could be beneficial. Suchwhich 10 crossovers were allowed between CYP102A1-h
a scaffold is also desirable for protein engineering.and CYP102A2-h, with the crossover positions chosen
Recent engineering efforts have demonstrated thatat random. Each library contains 211  2048 different
P450s can acquire new or improved activities by pointchimeric sequences. For each library, we calculated (1)
mutation [30, 35, 54]; here we show that recombinationthe fraction that is predicted to fold (using F30  fraction
of homologous sequences should be able to generateof sequences with E  30) and (2) the average level of
significant functional diversity as well. We proposeeffective mutation in these folded chimeras (m30). We
that SCHEMA can help identify appropriate crossoverfind that the choice of crossover points can dramatically
locations for large, combinatorial libraries [17], whichaffect these values and, in all likelihood, the distribution
can be generated using targeted recombination meth-and nature of functional proteins in the library. A library
ods [27, 58]. With appropriate high throughput screen-of CYP102A1-h and CYP102A2-h chimeras may contain
ing, we may then be able to discover new P450s withas little as 9% that fold properly; on average 42% will
fold. In contrast, by constructing libraries in silico and properties that nature has not yet needed or explored.
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Experimental Procedures lactopyranoside (IPTG)-inducible pCWori vector [28]. Cultures
grown in terrific broth (TB) were shaken at 250 rpm and 30	C until
they reached an OD600 of approximately 0.8. They were induced withMaterials
Enzymes for DNA manipulations were obtained from New England 0.6 mM IPTG, supplemented with 25 g/ml thiamine and 0.5 mM
-aminolevulinic acid, and grown for 20 hr at 180 rpm and 25	C.Biolabs (Beverly, MA) and Stratagene (La Jolla, CA). Synthetic oligo-
nucleotides were obtained from Invitrogen (Carlsbad, CA) or the This procedure yields approximately 80 mg/l of P450 protein for
CYP102A1 and CYP102A2. Cultures were pelleted at 5500 g for 15California Institute of Technology oligonucleotide facility. DNA purifi-
cation kits were from Zymo Research (Orange, CA) and Qiagen min, resuspended in 50 mM Tris (pH 8.2), and lysed by sonification.
Centrifugation was used to clear the supernatant, which was used(Valencia, CA). Other reagents and chemicals were from Fisher Sci-
entific (Pittsburgh, PA), Becton Dickinson (Franklin Lake, NJ), and for further assays.
Sigma Chemical Co. (St. Louis, MO).
Folding Assay
Carbon monoxide-reduced difference spectroscopy was performedCalculations
as reported [60]. Cell extracts were diluted into 800 l of 100 mMThe number of contacts broken by recombination (E ) was calculated
Tris buffer (pH 8.2) in a cuvette at room temperature. A few mg ofas described using coordinates from the substrate bound (1JPZ)
sodium hydrosulfite on the tip of a spatula were added, and a blankand substrate-free structures of CYP102A1 (2HPD) [16, 22, 26]. Hy-
spectrum was determined from 400 to 500 nm. Carbon monoxidedrogens, backbone nitrogens, backbone oxygens, and heme atoms
was bubbled in for 20 s at a rate of approximately one bubble perwere not included in the calculation. The sequences of CYP102A1
second. Two minutes were allowed to pass before a spectrum wasand CYP102A2 were aligned using ClustalW [59], revealing the exis-
taken. Spectra were determined at multiple times to ensure com-tence of a 1 amino acid insertion relative to CYP102A1, between
plete carbon monoxide binding and maximum absorbance. ThereQ229 and S230. This insertion was ignored in the calculations.
were no increases beyond 5 min of incubation with carbon monoxideCYP102A1 residues G227 and E228 were also ignored because
for any of the chimeras. P450 enzyme concentrations were quanti-they are unresolved in the substrate bound structure (1JPZ). For
fied for further assays using an extinction coefficient of 91 mol
1cm
1calculation of E and mutation for all double crossover chimeras,
for the absorbance difference between 448 nm and 490 nm.we applied a minimum insert size of 10 residues. The error values
reported for E and mutation represent one standard deviation.
The recombination libraries analyzed contained 10 randomly cho- Peroxygenase Activity
sen crossovers, each separated by a minimum of 10 residues. Using First-order rates of p-nitrophenolate accumulation were determined
the substrate bound structure of CYP102A1 (1JPZ) [22], we calcu- using 1 M enzyme, 20 mM H2O2, 250 M 12-pNCA, and 0.5%
lated the total number of contacts disrupted (E ) and effective level dimethyl sulfoxide (DMSO) in 100 mM Tris-HCl (pH 8.2) at room
of mutation (m ) for all 211 (2048) chimeras in 5000 libraries. We also temperature. Enzyme, substrate, buffer, and DMSO were combined
computed the fraction of chimeras in each library with E  30, in a cuvette and zeroed at 410 nm. Reaction mixtures were allowed
denoted F30, and the average effective level of mutation m30 in to incubate for 4 min and initiated by the addition of H2O2 to a final
this low-disruption fraction. concentration of 20 mM. Initial rates were determined by monitoring
the accumulation of p-nitrophenolate at 410 nm, and data from the
first 6 s were used to determine initial rates. If no activity was ob-Construction of Chimeras
served at 20 mM H2O2, a second trial at 100 mM was done. NoSelected chimeras were constructed using SOEing methods, as
chimera inactive at 20 mM H2O2 showed activity at the higher con-described previously [27]. Heme domain chimeras contained resi-
centration. The extinction coefficient of p-nitrophenolate is 13,200dues 1–463 from CYP102A1 or the corresponding residues in
M
1cm
1 [34]. All rates reported represent the average of three inde-CYP102A2 (1–466). Two primers consisting of a 5 sequence from
pendent experiments, with error bars corresponding to one standardone parent (A) and a 3 sequence from the other (B) that encompass
deviation.the crossover site were used to amplify the sequence to be inserted
Catalytic activities on 2-phenoxy-ethanol and allyloxy-benzene(B) with 25–30 bp overhangs from the other sequence (A). The PCR
were determined using 2 M enzyme, 20 mM H2O2, 1% DMSO, andprotocol was to heat the plasmids and primers at 95	C followed by
1% acetone in 100 mM N-[2-hydroxyethyl]piperazine-N-[3-pro-22 cycles of 95	C for 1 min, 48	C for 1 min, and 72	C for 2 min with
panesulfonic acid] (Epps) (pH 8.2) at room temperature. Substratea final extension at 72	C for 10 min. These products acted as primers
concentrations for 2-phenoxy-ethanol (100 mM) and allyloxy-ben-in a further PCR reaction along with forward and reverse primers
zene (50 mM) maintained saturation. Total reaction volumes wereexternal to the ends of the gene containing BamHI and EcoRI restric-
400 l for heme domain chimeras and were initiated by the additiontion sites, respectively, for cloning into the pCWori vector. The PCR
of H2O2 and monitored for up to 90 min. Aliquots of the reactionprotocol was 95	C for 1 min, 46	C for 1 min, and 72	 for 2 min for
were removed at time points within the linear region of the time22 cycles with a final extension at 72	C for 10 min. These two prod-
course and mixed with an equal volume of a solution containingucts were assembled in a two-step PCR reaction: 95	C for 1 min
4 M urea and 100 mM NaOH. 15 l per 100 l of 0.6% 4-AAP wasfollowed by 14 cycles of 95	C for 1 min, 46	C for 1 min, and 72	C
added, followed by mixing and addition of 15 l per 100 l of 0.6%for 2 min. External primers were added, followed by PCR 95	C for
potassium persulfate. Color was allowed to develop for 20 min be-1 min, then followed by 14 cycles of 95	C for 1 min, 46	C for 1 min,
fore absorbance was read at 500 nm. The major products wereand 72	C for 2 min, with a final extension of 72	C for 10 min. All
determined by GC/MS to be the hemiacetal, which decomposes toPCR products were gel-purified using the Zymoclean-5 column from
phenol. The extinction coefficient for the 4-AAP/phenol complexZymo Research. High-fidelity Pfu Turbo and Pfu Ultra polymerases
was determined to be 4800 M
1cm
1.(Stratagene) were used for PCR. Final products were digested with
BamHI and EcoRI and cloned into pCWori. Plasmids were trans-
formed into a catalase-deficient strain of E. coli. Chimeras were Monooxygenase Activity
sequenced at Laragen Inc. (Los Angeles, CA) and the California CRFP monooxygenase activities were determined under identical
Institute of Technology sequencing facility (Pasadena, CA) to con- conditions as the peroxygenase reactions, except H2O2 was re-
firm the sequences, with the absence of point mutations. pCWori placed with 500 M NADPH in all reactions.
expression vectors, encoding heme domain chimeras fused to the
N terminus of the CYP102A1 reductase domain (CRFP, chimera Clustering Analysis
reductase fusion proteins), were constructed for five of the chimeras Chimeras that retained the ability to fold were analyzed using hierar-
(43–135, 46–73, 118–184, 165–256, and 169–197) using a method chical clustering analysis as performed by the Spotfire software
similar to that described above. package (Spotfire, Somerville, MA). Chimeras were clustered based
on their substrate specificity profiles, i.e., whether or not they pos-
sessed measurable peroxygenase activity toward the substratesProtein Expression
Chimeric heme domains and CRFPs were expressed in catalase- 12-pNCA, 2-phenoxy-ethanol, and allyloxy-benzene. Therefore, ac-
tivities were normalized to the presence of activity (1) or the lack ofdeficient E. coli (strain SN0037) [29] using the isopropyl--D-thioga-
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activity (0). UPGMA (unweighted pair group method using arithmetic 12. Volkov, A.A., Shao, Z., and Arnold, F.H. (1999). Recombination
and chimeragenesis by in vitro heteroduplex formation and inaverages) clustering was performed using Euclidean distance as a
similarity metric and the average value as an ordering function. vivo repair. Nucleic Acids Res. 27, e18.
13. Kikuchi, M., Ohnishi, K., and Harayama, S. (2000). An effective
family shuffling method using single-stranded DNA. Gene 243,Peroxidase Activity
133–137.Peroxidase activities were measured by monitoring the accumula-
14. Lutz, S., Ostermeier, M., Moore, G.L., Maranas, C.D., and Ben-tion of the radical cation of ABTS at 414 nm [38]. Enzyme (1 M)
kovic, S.J. (2001). Creating multiple-crossover DNA libraries in-was mixed with 10 mM ABTS in 200 mM phosphate buffer (pH
dependent of sequence identity. Proc. Natl. Acad. Sci. USA 98,5.0) in a cuvette at room temperature. Samples were zeroed and
11248–11253.reactions were initiated with the addition of H2O2 to a concentration
15. Sieber, V., Martinez, C.A., and Arnold, F.H. (2001). Libraries ofof 20 mM. The absorbance at 414 nm was monitored for 5 min.
hybrid proteins from distantly related sequences. Nat. Biotech-Rates were determined from the initial slope of the time course
nol. 19, 456–460.(typically the first 30 s). An extinction coefficient of 36,000 mol
1cm
1
16. Voigt, C.A., Martinez, C., Wang, Z.G., Mayo, S.L., and Arnold,for ABTS was used.
F.H. (2002). Protein building blocks preserved by recombination.
Nat. Struct. Biol. 9, 553–558.Thermostability
17. Meyer, M.M., Silberg, J.J., Voigt, C.A., Endelman, J.B., Mayo,Cell extracts were heated in a thermocycler for 10 min at various
S.L., Wang, Z.G., and Arnold, F.H. (2003). Library analysis oftemperatures, followed by cooling to 4	C. Extracts were centrifuged
SCHEMA-guided protein recombination. Protein Sci. 12, 1686–for 5 min at 3500 g to remove any precipitates. Carbon monoxide-
1693.reduced difference spectroscopy was used to quantitate the amount
18. Narhi, L.O., Kim, B.H., Stevenson, P.M., and Fulco, A.J. (1983).of P450. The reduction of the carbon monoxide peak was monitored
Partial characterization of a barbiturate-induced cytochromeover a range of temperatures.
P-450-dependent fatty acid monooxygenase from Bacillus me-
gaterium. Biochem. Biophys. Res. Commun. 116, 851–858.Acknowledgments
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